Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

GLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere. In recent years, this class of weight-loss and Type 2 diabetes medication has become not only a household name but ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

One of the biggest sensations fueling the healthcare space right now is the medication class of glucagon-like peptide-1 (GLP-1 ... in its pursuit of the weight loss market, and assess whether ...

Unexpected weight loss. Muscles that hurt ... then the goal would be to combine them with GLP-1 agonist GSBR-1290 to treat patients with obesity. The third risk to consider would be in terms ...

For 52-year-old American property agent and aesthetician Kathryn Dean, diabetes drugs semaglutide and tirzepatide were key to achieving long-term weight loss – and preventing type-2 diabetes.

A new study suggests that GLP-1 agonist medications like Ozempic, which are used for diabetes management and weight loss, may help reduce the risk of overdose and alcohol intoxication in people ...